169 related articles for article (PubMed ID: 17442203)
1. Left ventricular endocardial pacing predicts the reduction of left ventricular outflow tract pressure gradient immediately after percutaneous transseptal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy refractory to medication.
Chen SL; Dai ZL; Li ZQ; Hu ZY; Ye F; Zhang JJ; Zhang FF; Luo J; Zhu ZS; Lin S; Wu CQ; Tian NL
Chin Med J (Engl); 2007 Apr; 120(7):562-8. PubMed ID: 17442203
[TBL] [Abstract][Full Text] [Related]
2. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
Krejcí J; Groch L; Meluzín J; Vykypel T; Halámek J; Vitovec J
Vnitr Lek; 2006 Apr; 52(4):313-20. PubMed ID: 16755987
[TBL] [Abstract][Full Text] [Related]
3. [Repeated percutaneous transluminal septal myocardial ablation leads to reduction of left ventricular outflow-tract pressure gradient in hypertrophic obstructive cardiomyopathy: a case report].
Takeda M; Mori T; Ohashi Y; Ichikawa S; Terashima M; Ejiri J; Awano K
J Cardiol; 2006 Jun; 47(6):313-21. PubMed ID: 16800375
[TBL] [Abstract][Full Text] [Related]
4. [Percutaneous transluminal septal myocardial ablation: early results and long-term follow-up].
Tekieli Ł; Pieniazek P; Podolec P; Tomkiewicz-Pajak L; Płazak W; Musiałek P; Leśniak-Sobelga A; Przewłocki T; Biernacka B; Zmudka K; Tracz W
Przegl Lek; 2006; 63(8):628-32. PubMed ID: 17441371
[TBL] [Abstract][Full Text] [Related]
5. Cardiac electromechanical mapping in analyzing the mechanism of left ventricular remodeling immediately after percutaneous transluminal septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Chen SL; Huang J; Ye F; Shan SJ; Zhang JJ; Duan BX; Chen YD
Chin Med J (Engl); 2005 Nov; 118(21):1779-85. PubMed ID: 16336814
[TBL] [Abstract][Full Text] [Related]
6. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].
Faber L; Seggewiss H; Fassbender D; Bogunovic N; Strick S; Schmidt HK; Gleichmann U
Z Kardiol; 1998 Mar; 87(3):191-201. PubMed ID: 9586154
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy.
Jiang T; Wu X; Jia C; Zhang Y; Lü Q
Chin Med J (Engl); 2002 Jan; 115(1):26-30. PubMed ID: 11930652
[TBL] [Abstract][Full Text] [Related]
8. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy.
Rigopoulos AG; Daci S; Pfeiffer B; Papadopoulou K; Neugebauer A; Seggewiss H
Clin Res Cardiol; 2016 Nov; 105(11):953-961. PubMed ID: 27270758
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography.
Faber L; Seggewiss H; Gleichmann U
Circulation; 1998 Dec; 98(22):2415-21. PubMed ID: 9832486
[TBL] [Abstract][Full Text] [Related]
10. [Percutaneous transluminal septal myocardial ablation combined with permanent dual-chamber pacing in hypertrophic obstructive cardiomyopathy: a case report].
Ochiai N; Furukawa K; Ebizawa T; Yagi T; Akashi K; Azuma A; Nakagawa M
J Cardiol; 2000 Nov; 36(5):331-6. PubMed ID: 11107555
[TBL] [Abstract][Full Text] [Related]
11. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Veselka J; Honek T
Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
[TBL] [Abstract][Full Text] [Related]
12. [Role of cardiac magnetic resonance on predicting outcome in patients with hypertrophic obstructive cardiomyopathy undergoing percutaneous transluminal septal myocardial ablation].
Du H; Lu M; Yin G; Yin X; Jiang Y; Wang J; Chen X; Song L; Huang J; Zhang Y; Zhao S
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Aug; 42(8):665-9. PubMed ID: 25388340
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
Seggewiss H; Faber L; Gleichmann U
Thorac Cardiovasc Surg; 1999 Apr; 47(2):94-100. PubMed ID: 10363608
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients.
Faber L; Meissner A; Ziemssen P; Seggewiss H
Heart; 2000 Mar; 83(3):326-31. PubMed ID: 10677415
[TBL] [Abstract][Full Text] [Related]
15. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].
Qiao SB; Gao RL; You SJ; Yuan JS; Chen JL; Yang YJ
Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):210-2. PubMed ID: 16624154
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
Guo H; Wang J; Chen J; Shan J; Lee JD; Ueda T
Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
[TBL] [Abstract][Full Text] [Related]
17. [Percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy: immediately and middle-term follow-up results].
Jiang T; Wu X; Jia C
Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):663-5. PubMed ID: 11769718
[TBL] [Abstract][Full Text] [Related]
18. [Anesthetic management of a patient with HOCM even after PTSMA].
Fujimoto H; Kamiya Y; Ohki H; Goto T
Masui; 2008 Oct; 57(10):1276-9. PubMed ID: 18975549
[TBL] [Abstract][Full Text] [Related]
19. Effect of biventricular pacing on left ventricular outflow tract pressure gradient in a patient with hypertrophic cardiomyopathy and normal interventricular conduction.
Komsuoglu B; Vural A; Agacdiken A; Ural D
J Cardiovasc Electrophysiol; 2006 Feb; 17(2):207-9. PubMed ID: 16533259
[TBL] [Abstract][Full Text] [Related]
20. Improved hypertrophic obstructive cardiomyopathy by left ventricular apex epicardial pacing.
Yufu K; Takahashi N; Ooie T; Shigematsu S; Hara M; Sako H; Miyamoto S; Hadama T; Tsuchiya T; Honda T; Yoshimatsu H; Saikawa T
Intern Med; 2004 Apr; 43(4):295-9. PubMed ID: 15168771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
